Ultragenyx to Pay $6 Million to Settle Alleged False Medicare, Medicaid Claims
Wall Street Journal
The Justice Department alleges Ultragenyx paid for free genetic tests for patients, and bought test results, to induce prescriptions of its drug Crysvita.